7 Analysts Have This to Say About Hologic
Within the last quarter, Hologic (NASDAQ:HOLX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…
Gartner, Sony, Uber And Other Big Gainers From Tuesday
U.S. stocks closed lower on Tuesday, with the Nasdaq Composite dropping around 100 points. Here is the list of some big stocks recording gains in the previous session.
Expert Ratings for Hologic
Hologic (NASDAQ:HOLX) has observed the following analyst ratings within the last quarter:
Hologic Q4 EPS $0.82 Beats $0.63 Estimate, Sales $953.00M Beat $866.76M Estimate
Hologic (NASDAQ:HOLX) reported quarterly earnings of $0.82 per share which beat the analyst consensus estimate of $0.63 by 30.16 percent. This is a 49.07 percent decrease over earnings of $1.61 per share from the same
Mizuho Initiates Coverage On Hologic with Buy Rating, Announces Price Target of $75
Mizuho analyst Anthony Petrone initiates coverage on Hologic (NASDAQ:HOLX) with a Buy rating and announces Price Target of $75.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au